正版 我的结合医学人生:陈可冀院士英文论文选集:selected papers

Table of Contents

Foreword

Views and Insights

1.My 60 Years of Traditional Chinese and Western Medicine Integration 003

2.Thanks for Your Accompanying in the Journey of lntegrative Medicine-Strength and Confidence from the Predecessors of Chinese Medical Association 009

3.Historical Responsibility and Great Trust of the Times-Review and Outlook of 60 Years of lntegrative Medicine Clinical Sciences 013

4.Where Are We Going? 016

5.Profiles of Traditional Chinese Medicine Schools 019

6.Complementary and Alternative Medicine: Is It Possible to Be Mainstream? 024

7.Convergence: The Tradition and The Modern 026

8.Chinese Medicine Pattern Diagnosis Could Lead to Innovation in Medical Sciences 029

9.Improving Clinical Practice Guideline Development in Integration of Traditional Chinese Medicine and Western Medicine 037

10.Bridging the Traditional Chinese Medicine Pattern Classification and Biomedical Disease Diagnosis with Systems Biology 040

11.Integration of Chinese Medicine with Western Medicine Could Lead to Future Medicine: Molecular Module Medicine 049

12.Integrative Medicine in Clinical Practice: From Pattern Differentiation in Traditional Chinese Medicine to Disease Treatment 057

13.Current Situation and Progress in Integrative Medicine in China 059

14.Clinical Service of Chinese Medicine 068

15.The Principle and Practice of lntegrative Chinese and Western Medicine 070

16.Clinical Features and Investigation of Traditional Chinese Medicine 074

17.Forty Years of lntegrated Medicine in China 078

18.Integrating Traditional Medicine with Biomedicine Towards a Patient-Centered Healthcare System 082

19.Making Evidence-based Decisions in the Clinical Practice of lntegrative Medicine 085

20.Herb-drug Interaction: An Emerging Issue of lntegrative Medicine 088

21.Atherosclerosis: An Integrative East-West Medicine Perspective 090

22.The Potential Benefit of Complementary/Alternative Medicine in Cardiovascular Diseases 095

23.Recent Clinical Trials of Acupuncture in the West: Responses from the Practitioners 096

24.Further Validation of the Health Scale of Trad/tional Chinese Medicine ( HSTCM ) 104

Clinical and Experimental Studies

1.The Traditional and the Contemporar-Complementary Nature of Chinese and Modern Medicine-A Speech at Nobel Laureate Summit and Academician Forum of Medicine ( 2014 ) 121

2.Certain Progress in the Treatment of Coronary Heart Disease with Traditional Medicinal Plants in China 125

3.XS0601 Reduces the Incidence of Restenosis: A Prospective Study of 335 Patients Undergoing Percutaneous Coronary Intervention in China 129

4.Blood Stasis Syndrome and Its Treatment with Activating Blood Circulation to Remove Blood Stasis Therapy 138

5.The Diagnostic Criteria of Blood-Stasis Syndrome: Considerations for Standard-ization of Pattern Identification 144

6.Multifactor Dimensionality Reduction Analysis of the Correlation of Chinese Medicine Syndrome Evolvement and Cardiovascular Events in Patients with Stable Coronary Heart Disease 152

7.Clinical Study of Xiongshao Capsule on Preventing Restenosis after Coronary Interventional Treatment 159

8.Paeoniflorin Promotes Angiogenesis in A Vascular Insufficiency Model of Zebr-afish in vivo and in Human Umbilical Vein Endothelial Cells in vitro 164

9.A Multi-Center Randomized Double-Blind Placebo-Controlled Trial of Xiongshao Capsule in Preventing Restenosis after Percutaneous Coronary Intervention: A Subgroup Analysis of Senile Patients 174

10.Effect of Xiongshao Capsule on the Function of Vascular Endothelium of Patients with Cervical Atherosclerosis 182

11.Inhibition of Vascular Remodelling in a Porcine Coronary Injury Model by Herbal Extract XS0601 187

12.The Effect of Xuefu Zhuyu Decoction on in vitro Endothelial Progenitor Cell Tube Formation 197

13.Effects of Active Components of Red Paeonia and Rhizoma Chuanxiong on Angiogenesis in Atherosclerosis Plaque in Rabbits 202

14.A Microarray Analysis of Angiogenesis Modulation Effect of Xuefu Zhuyu Decoction on Endothelial Cells 210

15.Research on the Correlation between Platelet Gelsolin and Blood-Stasis Syndrome of Coronary Heart Disease 216

16.Correlation between FcY R III A and Aortic Atherosclerotic Plaque Destabilization in ApoE Knockout Mice and Intervention Effects of Effective Components of Chuanxlong Rhizome and Red Peony Root 223

17.Effect of EphB4/EphrinB2 Reverse Signal on Angiogenesis Induced by Xuefu Zhuyu Capsule Containing Serum in Human Microvascular Endothelial Celll 230

18.In Vitro Angiogenesis Effect of Xuefu Zhuyu Decoction and Vascular Endothelial Growth Factor: A Comparison Study 237

19.Effect of Xuefu Zhuyu Pill on Platelet Activating Factor Expression in Patients with Unstable Angina Pectoris 245

20.Effect of Xuefu Zhuyu Pill on Patients with Carotid Atherosclerosis by Colour Doppler Ultrasonography 249

21.Effect of Chinese Herbal Drug-Containing Serum for Activating-Blood and Dispelling-Toxin on ox-LDL-Induced Inflammatory Factors' Expression in Endothelial Cells 250

22.The Effect of Xuefu Zhuyu Tang on Restraining Aortic Smooth Muscle Cell and the PDGF-A, c-myc Gene Expression in Atherosclerotic Rabbits 255

23.Objectified Study ofAbdomen Diagnosis on Blood Stasis Syndrome 260

24.Effect of Chinese Drugs for Activating Blood Circulation and Detoxifying on Indices of Thrombosis, Inflammatory Reaction, and Tissue Damage in A Rabbit Model of Toxin-Heat and Blood Stasis Syndrome 261

25.Study on the Relationship between Blood Stasis Syndrome and Clinical Pathology in 227 Patients with Primary Glomerular Disease 269

26.Differential Gene Expression Profiles in Coronary Heart Disease Patients of Blood Stasis Syndrome in Traditional Chinese Medicine and Clinical Role of Target Gene 277

27.Relationship between Platelet Activation Related Factors and Polymorphism of Related Genes in Patients with Coronary Heart Disease of Blood-stasis Syndrome 284

28.Chinese Herb and Formulas for Promoting Blood Circulation and Removing Blood Stasis and Antiplatelet Therapies 292

29.The Electron Microscopic Observation of Alkaloid No.l of Ligusticum Wallichii to the Influence of the Platelet of the Cases of Coronary Artery Heart Disease 302

30.Acute Hemodynamic Effects of Tetramethylpyrazine and Tetrandrine on Cirrhotic Rats 303

31.Haemodynamic Effects of Chronic Tetramethylpyrazine Administration on Portal Hypertensive Rats 308

32.Protective Effect of Propyl Gallate Against Oxidized Low-Density Lipoprotein-Induced Injury of Endothelial Cells 314

33.Effects ofPropyl Gallate on Carotid Artery Thrombosis and Coagulation/Fibrinolysis System in Rats 308

34.Effects of Propyl Gallate on Adhesion of Polymorphonuclear Leukocytes to HumanEndothelial Cells Induced by Tumor Necrosis Factor Alpha 327

35.Correlation between Platelet Gelsolin and Platelet Activation Level in Acute Myocardial Infarction Rats and Intervention Effect of Effective Components of Chuanxiong Rhizome and Red Peony Root 338

36.ITIH4 A New Potential Biomarker of "Toxin Syndrome" in Coronary Heart Disease Patient Identified with Proteomic Method 345

37.Mechanisms and Clinical Application of Tetramethylpyrazine ( an Interesting Natural Compound Isolated from Ligusticum Wallichii ) : Current Status and Perspective 358

38.Oral Chinese Proprietary Medicine for Angina Pectoris: An Overview of Syste-matic Reviews/Meta-analyses 369

39.Oral Panax notoginseng Preparation for Coronary Heart Disease: A Systematic Review of Randomized Controlled Trials 385

40.Effects of Extracts from Panax Notoginseng and Panax Ginseng Fruit on Vascular Endothelial Cell Proliferation and Migration in vitro 400

41.Platelet Proteomics and Its Advanced Application for Research of Blood Stasis Syndrome And Activated Blood Circulation Herbs of Chinese Medicine 406

42.Salvianolic acid B Suppresses Maturation of Human Monocyte-derived Dendritic Cells by Activating PPAR7 414

43.Systematic Review of Compound Danshen Dropping Pill: A Chinese Patent Medicine for Acute Myocardial Infarction 428

44.Tetramethylpyrazine in the Treatment of Cardiovascular and Cerebrovascular Diseases 445

45.The Effect of XuefuZhuyu Oral Liquid on Aspirin Resistance and Its Association with rs5911, rs5787, and rs3842788 Gene Polymorphisms 446

46.The Expression of CD14+CD16+ Monocyte Subpopulation in Coronary Heart Disease Patients with Blood Stasis Syndrome 453

47.Effect of Chinese Herbal Medicine for Activating Blood Circulation and Detoxifying on Expression of lnflammatory Reaction and Tissue Damage Related Factors in Experimental Carotid Artery Thrombosis Rats 460

48.Observation on the Analgesic Effect of Kuan-Xiong Aerosol on Anginal Attacks 466

49.Zedoary Guaiane-type Sesquiterpenes-eluting Stents Accelerate Endothelial Healing without Neointimal Hyperplasia in a Porcine Coronary Artery Model 469

Gerontology and Geriatrics

1.Some Key Problems and Thinkings on Gerontological Study in China 481

2.Refiections on Human Longevity and Chinese Medicine Prevention and Treatment of Chronic Diseases 487

3.Atherosclerosis, Vascular Aging and Therapeutic Strategies 493

4.The Essential Mechanisms of Aging: Irreparable Damage Accumulation of Bioche-mical Side-rsactions 498

5.The Clinical Research of Chinese Medicines for Retarding Aging Process 512

6.Anti-Aging Herbal Medicines in China 519

7.A Systematic Review of Xuezhikang, an Extract from Red Yeast Rice, for Coronary Heart Disease Complicated by Dyslipidemia 522

8.Natural Polypill Xuezhikang: Its Clinical Benefit and Potential Multicomponent Synergistic Mechanisms of Action in Cardiovascular Disease and Other Chronic Conditions 541

Original Archives Research for Qing Royal Palace Medical Experiences

1.Systematic and Scientific Research in Qing Court Medication Experiences 559

2.A Comprehensive Study on Shengmai San Oral-Liquid 561

3.Experimental Research on Anti-motion Sickness Effects by Chinese Medicine "Ping' andan" Pills in Cats 565

4.Clinical and Experimental Studies on the Retarding Effect of Qing Court Shoutao Pill on the Aging Process 570

5.The Effect of Qinggong Changchun Capsule on Decreased Fluid Intelligence Asssociated with Aging 575

Others

1.Effects of Panax Qt.tinquefolium Saponin on Phosphatidylinositol 3-Kinase/Serine Threonine Kinase Pathway ofNeonatal Rat Myocardial Cells Subjected to Hypoxia 581

2.Progress in the Research of Radix Astragaliin Treating Chronic Heart Failure: Effective Ingredients, Dose-Effect Relationship and Adverse Reaction 588

3.Effects of Tribuli Saponins on Left Ventricular Remodeling after Acute Myocardial Infarction in Rats with Hyperlipidemia 595

4.Advances in Experimental Pharmacological Studies of Effects ofAstragalus on Cardiovascular System 601

5.Research Progress on Mechanism of Action of Radix Astragalus in the Treatment of Heart Failure 608

6.Experimental Study on the Abstinence Effect of Herbal Preparation Composite Dongyuan Gao 616

7.Clinical Observations of AIDS Treated with Herbal Formulas 621

8.Acupuncture in Modern Medicine 625

9.Gua Sha, An Ancient Technical Management, for Certain Illness 627

10.Development Is A High Level Inheritance for China Time-honored Brand Products 629

11.New Findings Validate an Ancient Technique: How Massage Affects the Bioche-mistry of lnflammation 631

12.The Circadian Rhythm of Yin and Yang Syndrome on Hypertension 633

Postscript 637

陈可冀，中国科学院资历院士，国医大师，第七、八、九届全国政协委员，全国杰出专业技术人才，中国中医科学院首席研究员及终身研究员，香港浸会大学及澳门科技大学荣誉博士，长期从事心血管病与老年医学临床研究。现任中央保健委员会专家顾问委员会成员，中国科协荣誉委员，中华医学会及中国医师协会常务理事，中国药典委员会执委，中国中西医结合学会名誉会长，中国老年学学会名誉会长，中国医师协会中西医结合医师分会会长。北京大学医学部兼职教授，首都医科大学中西医结合学系学术委员会主任，世界中医药学会联合会不错专家顾问委员会。

评论

陈可冀院士历年来在国际期刊上发表的精选英文论文100篇左右。按照"血瘀证与活血化瘀"、"老年医学"、"清代宫廷医学研究"、"医学人文"、"杂选"等将其发表的英文论文合集出版。陈可冀院士历年来在国际期刊上发表的精选英文论文100篇左右。按照"血瘀证与活血化瘀"、"老年医学"、"清代宫廷医学研究"、"医学人文"、"杂选"等将其发表的英文论文合集出版。

导语_点评_词